OBL Pharm - Ownership and Business Overview

Healthcare ServicesCompany

OBL Pharm Ownership

Who owns OBL Pharm?

OBL Pharm is owned by UFG Private Equity. It was acquired on September 1, 2013.

Is OBL Pharm PE-backed?

Yes. OBL Pharm is owned by private equity investor UFG Private Equity.

OBL Pharm Business Overview

Where is OBL Pharm headquartered?

OBL Pharm is headquartered in Moscow, Russia.

What sector is OBL Pharm in?

OBL Pharm is a healthcare services company.

When was OBL Pharm founded?

OBL Pharm was founded in 1994.

Healthcare Services M&A Summary in 2013

Out of 60 sectors in the Mergr database, healthcare services ranked 5 in number of deals in 2013. The largest healthcare services acquisition in 2013 was Elan - which was acquired by Perrigo Company for $8.6B.

Join Mergr to view all 330 acquisitions of healthcare services companies in 2013, including 46 acquisitions by private equity firms, and 284 by strategics.

OBL Pharm

Building 11, 4th floor, 31 Shaboloyka Street,
Moscow, 115162
Russia,
+7 (495) 646-28-68
www.obolensk.ru

OBL Pharm is a generic drug manufacturer. The company is specializing in heart & blood as well as digestive system diseases and is currently producing over 100 types of drugs. Production facilities are located in the Moscow region (Obolensk) and its business strategy is focused on commercial sales channel and branded products. OBL Pharm was established in 1994 and is based in Moscow, Russia.


 Subscribe to unlock this and 201,688
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.